Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
Trastuzumab has recently shown efficacy in the treatment of HER2-positive advanced gastric adenocarcinoma. Although antibody-based therapies target the metastatic disease, HER2 status is usually evaluated in the primary tumour because metastatic sites are rarely biopsied. The aim of this study was t...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | engleski |
| Izdano: |
2011
|
| Online pristup: | https://doi.org/10.1038/bjc.2011.121 https://www.nature.com/articles/bjc2011121.pdf |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|